Metagenomics Market – Global Industry Analysis and Forecast (2023-2029)


Metagenomics Market size is expected to grow at 18.2% throughout the forecast period, reaching nearly US$ 6.97 Bn. by 2029.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.



To know about the Research Methodology:-Request Free Sample Report

Global Metagenomics Market , Dynamics:

The metagenomics market is segmented into the technology, product, application, and region.

In terms of technology, the global metagenomics market is classified into sequencing and bioinformatics. Based on the product, the market is divided into instruments, software, and consumables. A further application, global medical gas, and equipment market are split into environmental, human health, and others.

In terms of technology, the sequencing-driven segment accounted for the xx% share in the metagenomics market owing to the higher implementation of this technology. High adoption of this technology can be attributed to the advent of novel bioinformatics-related solutions, which simplifies workflows and provides rapid results.

Based on application, environmental applications segment is anticipated to grow at a faster CAGR during the forecast period. Environmental applications include use in the agriculture sector to support crop growth, bioremediation through wastewater treatment, clean-up of oil spills and gasoline leaks, and biofuel production by harnessing microbial power.

Metagenomics Market , Regional Analysis:

Geographically, the Asia-Pacific market is anticipated to the fastest-growing region for the market. The Asia-Pacific metagenomics market is anticipated to grow rapidly due to the high incidence of cancer, large prevalence of target diseases, growing healthcare expenditure, rise in investments and funds and various emerging applications.

The objective of the report is to present a comprehensive analysis of the Global Metagenomics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors in the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Metagenomics Market dynamics, structure by analyzing the market segments and project the Global Metagenomics Market size. Clear representation of competitive analysis of key players by End-User Industry, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Metagenomics Market make the report investor’s guide.

Metagenomics Market, Key Highlights:

Global Metagenomics Market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the market

Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Metagenomics Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Metagenomics Market are also profiled.

Metagenomics Market Scope: Inquire before buying






Global Metagenomics Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 2.16 Bn.




Forecast Period 2023 to 2029 CAGR:
18.2%
Market Size in 2029:
US $ 6.97Bn.




 Segments Covered:
by Technology
Sequencing
Bioinformatics




by Product
Instruments
Software
Consumables




by Application
Environmental
Human Health
Others






Metagenomics Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players:

1. QIAGEN
2. F. Hoffmann-La Roche Ltd
3. Illumina, Inc.
4. Novogene Corporation
5. PerkinElmer Inc.
6. Bio-Rad Laboratories
7. Thermo Fisher Scientific, Inc.
8. Merck KGaA
9. Agilent Technologies
10.Promega Corporation
11.Luminex Corporation
12.Oxford Gene Technology, Inc.
13.TAKARA BIO INC.
14.Danaher
15.ELITechGroup
16.AutoGenomics
17.Biocartis Group NV
18.IntegraGen.
19.ChunLab, Inc.
20.UBiome, Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Metagenomics Market?
Ans: Asia Pacific region held the highest share in 2022.

2. What is the growth rate of Global Metagenomics Market?
Ans: The market is expected to grow at a CAGR of 18.2% during forecast period 2023-2029.

3. What is scope of the Global Metagenomics market report?
Ans: Global Metagenomics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Metagenomics market?
Ans: The important key players in the market are – QIAGEN, F. Hoffmann-La Roche Ltd, Illumina, Inc., Novogene Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Promega Corporation, Luminex Corporation, Oxford Gene Technology, Inc., TAKARA BIO INC., Danaher, ELITechGroup, AutoGenomics, Biocartis Group NV, IntegraGen., ChunLab, Inc., UBiome, Inc

5. What is the study period of this market?
Ans: The Global Metagenomics Market is studied from 2022 to 2029. 





Global metagenomics market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
1.4. Key Questions Answered

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Metagenomics Market Size, by Market Value (US$ Mn) and Market, by Region

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.4. Global Metagenomics Market Industry Trends and Emerging Technologies

5. Global Metagenomics Market Analysis and Forecast
5.1. Global Metagenomics Market Analysis and Forecast
5.2. Global Metagenomics Market Size& Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America

6. Global Metagenomics Market Analysis and Forecast, by Technology
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Metagenomics Market Value Share Analysis, by Technology
6.4. Global Metagenomics Market Size (US$ Mn) Forecast, by Technology
6.5. Global Metagenomics Market Analysis, by Technology
6.6. Global Metagenomics Market Attractiveness Analysis, by Technology

7. Global Metagenomics Market Analysis and Forecast, by Product
7.1. Introduction and Definition
7.2. Global Metagenomics Market Value Share Analysis, by Product
7.3. Global Metagenomics Market Size (US$ Mn) Forecast, by Product
7.4. Global Metagenomics Market Analysis, by Product
7.5. Global Metagenomics Market Attractiveness Analysis, by Product

8. Global Metagenomics Market Analysis and Forecast, by Application
8.1. Introduction and Definition
8.2. Global Metagenomics Market Value Share Analysis, by Application
8.3. Global Metagenomics Market Size (US$ Mn) Forecast, by Application
8.4. Global Metagenomics Market Analysis, by Application
8.5. Global Metagenomics Market Attractiveness Analysis, by Application

9. Global Metagenomics Market Analysis, by Region
9.1. Global Metagenomics Market Value Share Analysis, by Region
9.2. Global Metagenomics Market Size (US$ Mn) Forecast, by Region
9.3. Global Metagenomics Market Attractiveness Analysis, by Region

10. North America Metagenomics Market Analysis
10.1. Key Findings
10.2. North America Metagenomics Market Overview
10.3. North America Metagenomics Market Value Share Analysis, by Technology
10.4. North America Metagenomics Market Forecast, by Technology
10.4.1. Sequencing
10.4.2. Bioinformatics
10.5. North America Metagenomics Market Value Share Analysis, by Product
10.6. North America Metagenomics Market Forecast, by Product
10.6.1. Instruments
10.6.2. Software
10.6.3. Consumables
10.7. North America Metagenomics Market Value Share Analysis, by Application
10.8. North America Metagenomics Market Forecast, by Application
10.8.1. Environmental
10.8.2. Human Health
10.8.3. Others
10.9. North America Metagenomics Market Value Share Analysis, by Country
10.10. North America Metagenomics Market Forecast, by Country
10.10.1. U.S.
10.10.2. Canada
10.11. North America Metagenomics Market Analysis, by Country
10.12. U.S. Metagenomics Market Forecast, by Technology
10.12.1. Sequencing
10.12.2. Bioinformatics
10.13. U.S. Metagenomics Market Forecast, by Product
10.13.1. Instruments
10.13.2. Software
10.13.3. Consumables
10.14. U.S. Metagenomics Market Forecast, by Application
10.14.1. Environmental
10.14.2. Human Health
10.14.3. Others
10.15. Canada Metagenomics Market Forecast, by Technology
10.15.1. Sequencing
10.15.2. Bioinformatics
10.16. Canada Metagenomics Market Forecast, by Product
10.16.1. Instruments
10.16.2. Software
10.16.3. Consumables
10.17. Canada Metagenomics Market Forecast, by Application
10.17.1. Environmental
10.17.2. Human Health
10.17.3. Others
10.18. North America Metagenomics Market Attractiveness Analysis
10.18.1. By Technology
10.18.2. By Product
10.18.3. By Application
10.19. PEST Analysis

11. Europe Metagenomics Market Analysis
11.1. Key Findings
11.2. Europe Metagenomics Market Overview
11.3. Europe Metagenomics Market Value Share Analysis, by Technology
11.4. Europe Metagenomics Market Forecast, by Technology
11.4.1. Sequencing
11.4.2. Bioinformatics
11.5. Europe Metagenomics Market Value Share Analysis, by Product
11.6. Europe Metagenomics Market Forecast, by Product
11.6.1. Instruments
11.6.2. Software
11.6.3. Consumables
11.7. Europe Metagenomics Market Value Share Analysis, by Application
11.8. Europe Metagenomics Market Forecast, by Application
11.8.1. Environmental
11.8.2. Human Health
11.8.3. Others
11.9. Europe Metagenomics Market Value Share Analysis, by Country
11.10. Europe Metagenomics Market Forecast, by Country
11.10.1. Germany
11.10.2. U.K.
11.10.3. France
11.10.4. Italy
11.10.5. Spain
11.10.6. Rest of Europe
11.11. Europe Metagenomics Market Analysis, by Country/ Sub-region
11.12. Germany Metagenomics Market Forecast, by Technology
11.12.1. Sequencing
11.12.2. Bioinformatics
11.13. Germany Metagenomics Market Forecast, by Product
11.13.1. Instruments
11.13.2. Software
11.13.3. Consumables
11.14. Germany Metagenomics Market Forecast, by Application
11.14.1. Environmental
11.14.2. Human Health
11.14.3. Others
11.15. U.K. Metagenomics Market Forecast, by Technology
11.15.1. Sequencing
11.15.2. Bioinformatics
11.16. U.K. Metagenomics Market Forecast, by Product
11.16.1. Instruments
11.16.2. Software
11.16.3. Consumables
11.17. U.K. Metagenomics Market Forecast, by Application
11.17.1. Environmental
11.17.2. Human Health
11.17.3. Others
11.18. France Metagenomics Market Forecast, by Technology
11.18.1. Sequencing
11.18.2. Bioinformatics
11.19. France Metagenomics Market Forecast, by Product
11.19.1. Instruments
11.19.2. Software
11.19.3. Consumables
11.20. France Metagenomics Market Forecast, by Application
11.20.1. Environmental
11.20.2. Human Health
11.20.3. Others
11.21. Italy Metagenomics Market Forecast, by Technology
11.21.1. Sequencing
11.21.2. Bioinformatics
11.22. Italy Metagenomics Market Forecast, by Product
11.22.1. Instruments
11.22.2. Software
11.22.3. Consumables
11.23. Italy Metagenomics Market Forecast, by Application
11.23.1. Environmental
11.23.2. Human Health
11.23.3. Others
11.24. Spain Metagenomics Market Forecast, by Technology
11.24.1. Sequencing
11.24.2. Bioinformatics
11.25. Spain Metagenomics Market Forecast, by Product
11.25.1. Instruments
11.25.2. Software
11.25.3. Consumables
11.26. Spain Metagenomics Market Forecast, by Application
11.26.1. Environmental
11.26.2. Human Health
11.26.3. Others
11.27. Rest of Europe Metagenomics Market Forecast, by Technology
11.27.1. Sequencing
11.27.2. Bioinformatics
11.28. Rest of Europe Metagenomics Market Forecast, by Product
11.28.1. Instruments
11.28.2. Software
11.28.3. Consumables
11.29. Rest of Europe Metagenomics Market Forecast, by Application
11.29.1. Environmental
11.29.2. Human Health
11.29.3. Others
11.30. Europe Metagenomics Market Attractiveness Analysis
11.30.1. By Technology
11.30.2. By Product
11.30.3. By Application
11.31. PEST Analysis

12. Asia Pacific Metagenomics Market Analysis
12.1. Key Findings
12.2. Asia Pacific Metagenomics Market Overview
12.3. Asia Pacific Metagenomics Market Value Share Analysis, by Technology
12.4. Asia Pacific Metagenomics Market Forecast, by Technology
12.4.1. Sequencing
12.4.2. Bioinformatics
12.5. Asia Pacific Metagenomics Market Value Share Analysis, by Product
12.6. Asia Pacific Metagenomics Market Forecast, by Product
12.6.1. Instruments
12.6.2. Software
12.6.3. Consumables
12.7. Asia Pacific Metagenomics Market Value Share Analysis, by Application
12.8. Asia Pacific Metagenomics Market Forecast, by Application
12.8.1. Environmental
12.8.2. Human Health
12.8.3. Others
12.9. Asia Pacific Metagenomics Market Value Share Analysis, by Country
12.10. Asia Pacific Metagenomics Market Forecast, by Country
12.10.1. China
12.10.2. India
12.10.3. Japan
12.10.4. ASEAN
12.10.5. Rest of Asia Pacific
12.11. Asia Pacific Metagenomics Market Analysis, by Country/ Sub-region
12.12. China Metagenomics Market Forecast, by Technology
12.12.1. Sequencing
12.12.2. Bioinformatics
12.13. China Metagenomics Market Forecast, by Product
12.13.1. Instruments
12.13.2. Software
12.13.3. Consumables
12.14. China Metagenomics Market Forecast, by Application
12.14.1. Environmental
12.14.2. Human Health
12.14.3. Others
12.15. India Metagenomics Market Forecast, by Technology
12.15.1. Sequencing
12.15.2. Bioinformatics
12.16. India Metagenomics Market Forecast, by Product
12.16.1. Instruments
12.16.2. Software
12.16.3. Consumables
12.17. India Metagenomics Market Forecast, by Application
12.17.1. Environmental
12.17.2. Human Health
12.17.3. Others
12.18. Japan Metagenomics Market Forecast, by Technology
12.18.1. Sequencing
12.18.2. Bioinformatics
12.19. Japan Metagenomics Market Forecast, by Product
12.19.1. Instruments
12.19.2. Software
12.19.3. Consumables
12.20. Japan Metagenomics Market Forecast, by Application
12.20.1. Environmental
12.20.2. Human Health
12.20.3. Others
12.21. ASEAN Metagenomics Market Forecast, by Technology
12.21.1. Sequencing
12.21.2. Bioinformatics
12.22. ASEAN Metagenomics Market Forecast, by Product
12.22.1. Instruments
12.22.2. Software
12.22.3. Consumables
12.23. ASEAN Metagenomics Market Forecast, by Application
12.23.1. Environmental
12.23.2. Human Health
12.23.3. Others
12.24. Rest of Asia Pacific Metagenomics Market Forecast, by Technology
12.24.1. Sequencing
12.24.2. Bioinformatics
12.25. Rest of Asia Pacific Metagenomics Market Forecast, by Product
12.25.1. Instruments
12.25.2. Software
12.25.3. Consumables
12.26. Rest of Asia Pacific Metagenomics Market Forecast, by Application
12.26.1. Environmental
12.26.2. Human Health
12.26.3. Others
12.27. Asia Pacific Metagenomics Market Attractiveness Analysis
12.27.1. By Technology
12.27.2. By Product
12.27.3. By Application
12.28. PEST Analysis

13. Middle East & Africa Metagenomics Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Metagenomics Market Overview
13.3. Middle East & Africa Metagenomics Market Value Share Analysis, by Technology
13.4. Middle East & Africa Metagenomics Market Forecast, by Technology
13.4.1. Sequencing
13.4.2. Bioinformatics
13.5. Middle East & Africa Metagenomics Market Value Share Analysis, by Product
13.6. Middle East & Africa Metagenomics Market Forecast, by Product
13.6.1. Instruments
13.6.2. Software
13.6.3. Consumables
13.7. Middle East & Africa Metagenomics Market Value Share Analysis, by Application
13.8. Middle East & Africa Metagenomics Market Forecast, by Application
13.8.1. Environmental
13.8.2. Human Health
13.8.3. Others
13.9. Middle East & Africa Metagenomics Market Value Share Analysis, by Country
13.10. Middle East & Africa Metagenomics Market Forecast, by Country
13.10.1. GCC
13.10.2. South Africa
13.10.3. Rest of Middle East & Africa
13.11. Middle East & Africa Metagenomics Market Analysis, by Country/ Sub-region
13.12. GCC Metagenomics Market Forecast, by Technology
13.12.1. Sequencing
13.12.2. Bioinformatics
13.13. GCC Metagenomics Market Forecast, by Product
13.13.1. Instruments
13.13.2. Software
13.13.3. Consumables
13.14. GCC Metagenomics Market Forecast, by Application
13.14.1. Environmental
13.14.2. Human Health
13.14.3. Others
13.15. South Africa Metagenomics Market Forecast, by Technology
13.15.1. Sequencing
13.15.2. Bioinformatics
13.16. South Africa Metagenomics Market Forecast, by Product
13.16.1. Instruments
13.16.2. Software
13.16.3. Consumables
13.17. South Africa Metagenomics Market Forecast, by Application
13.17.1. Environmental
13.17.2. Human Health
13.17.3. Others
13.18. Rest of Middle East & Africa Metagenomics Market Forecast, by Technology
13.18.1. Sequencing
13.18.2. Bioinformatics
13.19. Rest of Middle East & Africa Metagenomics Market Forecast, by Product
13.19.1. Instruments
13.19.2. Software
13.19.3. Consumables
13.20. Rest of Middle East & Africa Metagenomics Market Forecast, by Application
13.20.1. Environmental
13.20.2. Human Health
13.20.3. Others
13.21. Middle East & Africa Metagenomics Market Attractiveness Analysis
13.21.1. By Technology
13.21.2. By Product
13.21.3. By Application
13.22. PEST Analysis

14. Latin America Metagenomics Market Analysis
14.1. Key Findings
14.2. Latin America Metagenomics Market Overview
14.3. Latin America Metagenomics Market Value Share Analysis, by Technology
14.4. Latin America Metagenomics Market Forecast, by Technology
14.4.1. Sequencing
14.4.2. Bioinformatics
14.5. Latin America Metagenomics Market Value Share Analysis, by Product
14.6. Latin America Metagenomics Market Forecast, by Product
14.6.1. Instruments
14.6.2. Software
14.6.3. Consumables
14.7. Latin America Metagenomics Market Value Share Analysis, by Application
14.8. Latin America Metagenomics Market Forecast, by Application
14.8.1. Environmental
14.8.2. Human Health
14.8.3. Others
14.9. Latin America Metagenomics Market Value Share Analysis, by Country
14.10. Latin America Metagenomics Market Forecast, by Country
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Latin America Metagenomics Market Analysis, by Country/ Sub-region
14.12. Brazil Metagenomics Market Forecast, by Technology
14.12.1. Sequencing
14.12.2. Bioinformatics
14.13. Brazil Metagenomics Market Forecast, by Product
14.13.1. Instruments
14.13.2. Software
14.13.3. Consumables
14.14. Brazil Metagenomics Market Forecast, by Application
14.14.1. Environmental
14.14.2. Human Health
14.14.3. Others
14.15. Mexico Metagenomics Market Forecast, by Technology
14.15.1. Sequencing
14.15.2. Bioinformatics
14.16. Mexico Metagenomics Market Forecast, by Product
14.16.1. Instruments
14.16.2. Software
14.16.3. Consumables
14.17. Mexico Metagenomics Market Forecast, by Application
14.17.1. Environmental
14.17.2. Human Health
14.17.3. Others
14.18. Rest of Latin America Metagenomics Market Forecast, by Technology
14.18.1. Sequencing
14.18.2. Bioinformatics
14.19. Rest of Latin America Metagenomics Market Forecast, by Product
14.19.1. Instruments
14.19.2. Software
14.19.3. Consumables
14.20. Rest of Latin America Metagenomics Market Forecast, by Application
14.20.1. Environmental
14.20.2. Human Health
14.20.3. Others
14.21. Latin America Metagenomics Market Attractiveness Analysis
14.21.1. By Technology
14.21.2. By Product
14.21.3. By Application
14.22. PEST Analysis

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.3. Company Profiles: Key Players
15.3.1. 3M
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Business Strategy
15.3.1.4. Recent Developments
15.3.1.5. Manufacturing Footprint
15.3.2. QIAGEN
15.3.3. F. Hoffmann-La Roche Ltd
15.3.4. Illumina, Inc.
15.3.5. Novogene Corporation
15.3.6. PerkinElmer Inc.
15.3.7. Bio-Rad Laboratories
15.3.8. Thermo Fisher Scientific, Inc.
15.3.9. Merck KGaA
15.3.10. Agilent Technologies
15.3.11. Promega Corporation
15.3.12. Luminex Corporation
15.3.13. Oxford Gene Technology, Inc.
15.3.14. TAKARA BIO INC.
15.3.15. Danaher
15.3.16. ELITechGroup
15.3.17. AutoGenomics
15.3.18. Biocartis Group NV
15.3.19. IntegraGen.
15.3.20. ChunLab, Inc.
15.3.21. UBiome, Inc.

16. Primary Key Insights
  • INQUIRE BEFORE BUYING